reGeneRative bone Implant for the treatment of hip dysPlasia

GRIP develops a personalised, 3D-printed regenerative bone implant as a treatment for hip instability (hip dysplasia) and its commercialisation strategy. Osteoarthritis (OA) of the hip is a painful and debilitating condition and hip dysplasia is one of the two main causes.

The currently most common surgical methods to correct the dysplasia involve the re-alignment of the hip socket (osteotomy) or the insertion of a bone graft to enlarge the socket (shelf arthroplasty). While the osteotomy is invasive, the shelf arthroplasty requires donor tissue. In addition, both procedures only have limited success rates.

GRIP implants overcome the current shortcomings of these methods and provide a novel personalized implant to treat hip dysplasia.

GRIP will provide patients and surgeons with an easy to use, one-step and cost-effective regenerative device, therefore overcoming the significant drawbacks with current treatments for hip dysplasia.

The GRIP implants will be precisely fabricated from a flexible bone-inducing biomaterial through a process both developed and established within the ERC-CoG “3D-JOINT” project.

This will ensure a perfect fit, resulting in optimal integration and durable restoration of the hip socket, as well as obviating the need for complex and invasive osteotomy surgeries.

GRIP implants will revolutionise the treatment of hip dysplasia as they provide a stable, long-term, and regenerative solution that will fully integrate with the host bone tissue. Moreover, the regenerative nature will also make this a potential treatment option for younger (paediatric) patients.

As GRIP will transform the treatment of hip dysplasia and will improve long-term health and well-being of both human and veterinary patients the economic value and the route to the market for the GRIP technologies will be explored.